Page last updated: 2024-09-03

nitroaspirin and Breast Cancer

nitroaspirin has been researched along with Breast Cancer in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chattopadhyay, M; Kashfi, K; Kodela, R; Nath, N; Nazarenko, A; Rodes, DB	1
Chattopadhyay, M; Kashfi, K; Kogan, M; Nath, N; Vassell, R	1

Other Studies

2 other study(ies) available for nitroaspirin and Breast Cancer

Article	Year
Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo. Molecules (Basel, Switzerland), 2015, Jul-09, Volume: 20, Issue:7 Topics: Animals; Antineoplastic Agents; Apoptosis; Aspirin; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Inhibitory Concentration 50; Injections, Subcutaneous; Luciferases; Mice; Mice, Nude; NF-kappa B; Proliferating Cell Nuclear Antigen; Reactive Oxygen Species; Receptor, ErbB-2; Receptors, Estrogen; Signal Transduction; Xenograft Model Antitumor Assays	2015
Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling. Biochemical pharmacology, 2009, Nov-15, Volume: 78, Issue:10 Topics: Anticarcinogenic Agents; Aspirin; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; beta Catenin; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; DNA-Binding Proteins; Down-Regulation; Enzyme Induction; Female; Genes, Reporter; Humans; Inhibitory Concentration 50; Isomerism; Signal Transduction; Transcription Factor 4; Transcription Factors; Transcription, Genetic; Wnt Proteins	2009

Article

Year

Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.

Molecules (Basel, Switzerland), 2015, Jul-09, Volume: 20, Issue:7

Topics: Animals; Antineoplastic Agents; Apoptosis; Aspirin; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Inhibitory Concentration 50; Injections, Subcutaneous; Luciferases; Mice; Mice, Nude; NF-kappa B; Proliferating Cell Nuclear Antigen; Reactive Oxygen Species; Receptor, ErbB-2; Receptors, Estrogen; Signal Transduction; Xenograft Model Antitumor Assays

2015

Nitro-aspirin inhibits MCF-7 breast cancer cell growth: effects on COX-2 expression and Wnt/beta-catenin/TCF-4 signaling.

Biochemical pharmacology, 2009, Nov-15, Volume: 78, Issue:10

Topics: Anticarcinogenic Agents; Aspirin; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; beta Catenin; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclooxygenase 2; DNA-Binding Proteins; Down-Regulation; Enzyme Induction; Female; Genes, Reporter; Humans; Inhibitory Concentration 50; Isomerism; Signal Transduction; Transcription Factor 4; Transcription Factors; Transcription, Genetic; Wnt Proteins

2009